Magenta Therapeutics, Inc.MGTANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | -95.45% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | -226.65% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | -226.65% |
| Weighted Average Shares Growth | +22.39% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Diluted Growth | +22.39% | +0.00% | +0.00% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +92.68% | -95.33% | +286.70% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +375.61% | +81.12% | -11.62% | +63.01% | +41.95% |
| Book Value per Share Growth | +286.03% | +84.22% | -15.39% | +61.72% | +39.98% |
| Debt Growth | +0.00% | +108.36% | +226.78% | +313.18% | -7.04% |
| R&D Expense Growth | +48109.35% | +239.23% | +45.27% | +27.19% | -10.62% |
| SG&A Expenses Growth | -9.35% | -15.89% | +47.89% | +25.54% | +105.97% |